Another model uses high-fat-fed mice treated with the endothelial nitric oxide synthase (eNOS) inhibitor l-NAME (Nω-Nitro-l-arginine methyl ester) to induce endothelial dysfunction-based hypertension, a widely used approach (19). Here, NOS3 is linked to hypertensive disorder.